A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses
- PMID: 15654865
- DOI: 10.1111/j.1460-9568.2004.03833.x
A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses
Abstract
The slow Wallerian degeneration phenotype, Wld(S), which delays Wallerian degeneration and axon pathology for several weeks, has so far been studied only in mice. A rat model would have several advantages. First, rats model some human disorders better than mice. Second, the larger body size of rats facilitates more complex surgical manipulations. Third, rats provide a greater yield of tissue for primary culture and biochemical investigations. We generated transgenic Wld(S) rats expressing the Ube4b/Nmnat1 chimeric gene in the central and peripheral nervous system. As in Wld(S) mice, their axons survive up to 3 weeks after transection and remain functional for at least 1 week. Protection of axotomized nerve terminals is stronger than in mice, particularly in one line, where 95-100% of neuromuscular junctions remained intact and functional after 5 days. Furthermore, the loss of synaptic phenotype with age was much less in rats than in mice. Thus, the slow Wallerian degeneration phenotype can be transferred to another mammalian species and synapses may be more effectively preserved after axotomy in species with longer axons.
Similar articles
-
The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice.Brain. 2005 Feb;128(Pt 2):405-16. doi: 10.1093/brain/awh368. Epub 2005 Jan 11. Brain. 2005. PMID: 15644421
-
Axotomy-dependent and -independent synapse elimination in organ cultures of Wld(s) mutant mouse skeletal muscle.J Neurosci Res. 2004 Apr 1;76(1):64-75. doi: 10.1002/jnr.20016. J Neurosci Res. 2004. PMID: 15048930
-
Atrophy and degeneration in sciatic nerve of presymptomatic mice carrying the Huntington's disease mutation.Brain Res. 2008 Jan 10;1188:61-8. doi: 10.1016/j.brainres.2007.06.059. Epub 2007 Jul 14. Brain Res. 2008. PMID: 18062944
-
Axon degeneration mechanisms: commonality amid diversity.Nat Rev Neurosci. 2005 Nov;6(11):889-98. doi: 10.1038/nrn1788. Nat Rev Neurosci. 2005. PMID: 16224497 Review.
-
Wallerian degeneration, wld(s), and nmnat.Annu Rev Neurosci. 2010;33:245-67. doi: 10.1146/annurev-neuro-060909-153248. Annu Rev Neurosci. 2010. PMID: 20345246 Free PMC article. Review.
Cited by
-
Retinal ganglion cell survival and axon regeneration in WldS transgenic rats after optic nerve crush and lens injury.BMC Neurosci. 2012 Jun 6;13:56. doi: 10.1186/1471-2202-13-56. BMC Neurosci. 2012. PMID: 22672534 Free PMC article.
-
Glycolytic System in Axons Supplement Decreased ATP Levels after Axotomy of the Peripheral Nerve.eNeuro. 2023 Mar 20;10(3):ENEURO.0353-22.2023. doi: 10.1523/ENEURO.0353-22.2023. Print 2023 Mar. eNeuro. 2023. PMID: 36894321 Free PMC article.
-
Differential proteomics analysis of synaptic proteins identifies potential cellular targets and protein mediators of synaptic neuroprotection conferred by the slow Wallerian degeneration (Wlds) gene.Mol Cell Proteomics. 2007 Aug;6(8):1318-30. doi: 10.1074/mcp.M600457-MCP200. Epub 2007 Apr 29. Mol Cell Proteomics. 2007. PMID: 17470424 Free PMC article.
-
Wallerian degeneration: an emerging axon death pathway linking injury and disease.Nat Rev Neurosci. 2014 Jun;15(6):394-409. doi: 10.1038/nrn3680. Nat Rev Neurosci. 2014. PMID: 24840802 Review.
-
Mouse Models of NMNAT1-Leber Congenital Amaurosis (LCA9) Recapitulate Key Features of the Human Disease.Am J Pathol. 2016 Jul;186(7):1925-1938. doi: 10.1016/j.ajpath.2016.03.013. Epub 2016 May 18. Am J Pathol. 2016. PMID: 27207593 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials